3 latest FDA approvals

Here are the three latest drugs or medical devices approved by the FDA since June 29:

Advertisement

1. Aristada Initio is an alternative, extended-release version of Aristada, a long-acting injectable antipsychotic used to treat adults with schizophrenia. 

2. The Zephyr Endobronchial Valve is implanted into a patient’s lung to treat breathing issues associated with severe emphysema.

3. Xeomin is intended to treat chronic sialorrhea, or excessive drooling, in adults.

More articles on supply chain:
10 most-read supply chain stories in June
CMS grants Oklahoma’s amendment to negotiate value-based rebates with drugmakers
FDA releases 2nd draft of its software pre-certification program

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Rethinking Safety and Security in the Healthcare Environment

Thursday, July 23
1:00 PM - 2:00 PM CDT

Presenters: Jon Share, AxonDan Snyder, Advocate HealthKeith Hunter, Wellstar

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.